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INTRODUCTION
Crohn’s disease (CD) is a chronic relapsing inflammatory
bowel disease affecting any part of the gastrointestinal tract,
but most commonly, the terminal ileum (Horsthuis et al.,
2008). The overall goal of CD treatment is to achieve and
maintain remission. Therefore, monitoring disease activity
is crucial during the course of the disease. Ileocolonoscopy
with histopathological sampling is the method of choice in
assessment of IBD. However, apart from causing general
patient discomfort (Buisson et al., 2017), visualisation ren-
dered by endoscopy is limited to the terminal ileum and co-
lon, and only superficial tissues from the luminal side can
be viewed and sampled (Van Rheenen et al., 2010). Wire-
less capsule endoscopy allows an advance beyond the reach
of a conventional endoscope by visualising intestinal mu-
cosa throughout its entire length in case of a non-stricturing
disease (Triester et al., 2006). Nevertheless, this modality,
like conventional endoscopy, does not allow assessment of
bowel wall tissue beyond mucosa. Therefore, cross-sec-
tional imaging is the only solution to assess the bowel wall
throughout its entire thickness.
When considering the superior soft-tissue resolution, non-
invasiveness and ability to obtain findings within entire
bowel wall thickness and around the bowel, and lack of ion-
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The MR activity indices used for quantification and follow-up of Crohn’s disease are composed of
a number of subjectively determinable components with equivocal repeatability. The purpose of
this article was to assess the repeatability of measurements used for quantitative estimation of
Crohn’s disease activity in the terminal ileum. In five adults (23–57 y.o.) and 12 children (10–17
y.o.) with active terminal ileitis, the inflamed bowel was divided into 3 cm segments (n = 32 in
adults, n = 46 in children), and measurements for the calculation of MaRIA and Clermont scores
were performed. Parameters included apparent diffusion coefficients (ADC) for diffusion-weighted
imaging (DWI) sequences with selective and non-selective fat suppression, wall signal enhance-
ment before (WSI-preGd) and after (WSI-preGd) gadolinium enhancement, bowel thickness, and
presence of ulcers. The measurements were standardised (accurate site-to-site comparison, ex-
act ROI size, where applicable) and repeated by the same researcher after two months. Intra-ob-
server agreement for ADC, WSI-preGd and WSI-postGd, bowel thickness was assessed with a
paired t-test, and the significant difference in presence/absence of ulcers was assessed by the
Pearson 2 test. Absolute difference was not found between the 1st and 2nd measurements of
ADC, WSI-preGd, WSI-postGd and wall thickness. There was systematic difference in the pres-
ence of bowel ulcers. In standardised conditions the repeatability of ADC, WSI-preGd and
WSI-postGd is high. Efforts must be made to precisely define the size and appearance of ulcers
that may be included in the index calculation.
Key words: Terminal ileitis, magnetic resonance enterography, Clermont score, MaRIA, activity
indices, intra-observer agreement.
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ising radiation, magnetic resonance enterography (MRE)
has been shown to be an informative imaging modality, ca-
pable of evaluating disease activity in IBD (Foti et al.,
2015). Numerous attempts have been made to develop scor-
ing systems for less invasive but informative quantification
of disease activity in the intestines. Examples of these scor-
ing systems include: Magnetic Resonance Index of Activity
(MaRIA), Clermont score, Crohn’s disease MRI index
(CDMI), Magnetic Resonance Enterography Global Score
(MEGS), Lemann index (Rozendorn et al., 2018), as well as
London index (Steward et al., 2012). Presently, the MaRIA
score is the only validated radiological CD activity index
tested in large patient populations (Dohan et al., 2016),
which has high and significant correlation with the Chron’s
Disease Endoscopic Activity Index. The MaRIA score is
composed of values of intestinal wall thickness and relative
contrast enhancement (RCE), as well as rating of presence
of oedema and ulcers in the bowel wall. RCE is calculated
from wall signal intensity (WSI) series before (WSI-preGd)
and after (WSI-postGd) administration of gadolinium con-
trast agent (Rimola et al., 2009). However, gadolinium ad-
ministration is related to potentially severe adverse reac-
tions like systemic nephrogenic fibrosis (Broome et al.,
2008) and accumulation of gadolinium deposits in the brain
(Gulani et al., 2017) and other body tissues (Quattrocchi et
al., 2017). The Clermont score, an alternative MRI index of
activity, has been developed on the basis of diffusion
weighted imaging (DWI) by replacing RCE with the appar-
ent diffusion coefficient (ADC), which is a numerical mea-
surement of diffusion restriction and is calculated from
DWI images (Hordonneau et al., 2014). The Clermont score
is, therefore, also called DWI-MaRIA. It is reported to have
an excellent correlation with the MaRIA score (Rimola et
al., 2009) and a moderate correlation with CDEIS (Buisson
et al., 2017), but further confirmatory studies are needed to
validate the Clermont score.
There is equivocal data available on the repeatability of
measurements used for calculation of MaRIA and Clermont
scores. No standardised technique of performing measure-
ments and assessment of ulcers is described in most of the
available publications, possibly influencing repeatability.
The goal of our study was therefore to assess intra-observer
agreement on measurements performed for calculation of
MaRIA and Clermont scores. Measurements such as
ADC-DWI, wall signal intensity (WSI) before (WSI-preGd)
and after (WSI-postGd) administration of gadolinium con-
trast medium contributing in relative contrast enhancement
(RCE), were performed to define the proper size of region
of interest (ROI) and to provide accurate site-to-site com-
parison. Intra-observer variability of the wall thickness and
detection of presence of ulcers was also analysed.
MATERIALS AND METHODS
This prospective observational cross-sectional study was
conducted in accordance with the Declaration of Helsinki.
Before inclusion in the study, written informed consent was
received from all patients or their legal representatives. Ap-
proval (permission number 6/10.09.2015) was obtained
from the Ethics Committee of Rîga Stradiòð University.
Patients. The study involved 17 patients (five adults, 23–57
y.o., and 12 children, 10–17 y.o.; see Table 1 for details)
with faecal calprotectin levels over 1000 g/mg and histo-
logically proven active Crohn’s non-stricturising and non-
penetrating disease in the terminal ileum, and signs of ac-
tive Crohn’s disease in MRE examination. These signs in-
cluded: 1) small bowel wall thickness > 3 mm, 2) presence
of mural oedema — hyperintensity of the bowel wall in
T2-weighted images compared to that in the psoas muscle
(Rimola et al., 2009), 3) signs of active inflammation in
conventional DWI sequence — high SI in DWI tracking im-
ages of b = 800 s/mm2, 4) low signal intensity (SI) in the
ADC map, and 5) early mucosal hyperenhancement in the
series following administration of gadolinium contrast agent
(post-Gd) (Moy et al., 2016). CD located outside the termi-
nal ileum, areas of bowel thickness less than 3 mm, lack of
signs of active bowel wall inflammation in DWI, DWIBS
and post-Gd T1 series within one and the same segments,
and dynamic blurring in either of the DWI or T1 post-Gd
images were not accepted for performing measurements.
According to the Montreal and Paris classification of CD
(Moon, 2019), the phenotype of 10 patients was A1 L1 B1;
the phenotype of the remaining seven patients was A2 L1
B1.
MRI technique. All patients were examined without prior
bowel cleansing. Fasting was required six hours prior to
MRE procedures. Patients were asked to slowly intake
1.000–1.500 ml of 2.5% peroral mannitol solution 45 min-
utes prior to the MRI procedure, and then to lie in the right
decubitus position, drinking extra 250 ml of 2.5% mannitol
solution for another 20 minutes. The MRE examinations
were performed with a 1.5T MRI scanner (Ingenia, Philips
Medical Systems, Best, the Netherlands) covering the re-
gion from the diaphragm to the pelvis with a 16-channel
body coil. All patients were scanned in the prone position.
The MRE protocol included:
1) coronal breath-hold balanced turbo field echo (bTFE)
cine sequence for real-time assessment of the bowel peri-
stalsis,
2) axial and coronal breath-hold Turbo Spin Echo, T2-
weighted sequences without fat suppression (T2 TSE),
3) axial and coronal breath-hold Spectral Attenuated Inver-
sion Recovery T2-weighted sequences with fat suppression
(T2 SPAIR),
Table 1. Demographic data of patients included in the study
Data Adult group Paediatric group
Gender Males, n = 4; females, n = 1 Males; n = 9, females; n = 3
Age 23 y.o.; n = 1, 25 y.o.; n = 1,
36 y.o.; n = 1, 40 y.o.; n = 1,
57 y.o.; n = 1
11 y.o.; n = 2, 12 y.o.; n = 3,
13 y.o.; n = 1, 14 y.o.; n= 4,
17 y.o.; n = 2
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4) axial respiratory triggered Spectral Presaturation Inver-
sion Recovery (SPIR) based DWI sequence using diffusion
factors b fixed at 0, 600 and 800 s/mm2 with the corre-
sponding ADC map,
5) axial free-breathing Short Tau Inversion Recovery
(STIR)-based DWI sequence using diffusion factors b fixed
at 0, 600 and 800 s/mm2 with the corresponding ADC map,
6) coronal respiratory triggered T2 fat suppression magnetic
resonance cholangiopancreatography (MRCP) sequence
with radial 3D reconstructions,
7) coronal breath-hold dynamic T1-weighted High-Reso-
lution Isotropic Volume (THRIVE), where scanning was
started simultaneously with intravenous administration of
gadolinium contrast media. Gadodiamide (Omniscan)
0.05 mmol/ml, GE Healthcare, dosage 0.2 ml/kg, or
0.1 mmol/kg was used in patients before October 2018, ex-
cept in two children examined after October 2018, who re-
ceived gadobutrol (Gadovist) 1 mmol/ml, Bayer, dosage
0.1 ml/kg, or 0.1 mmol/kg.
To stop intestinal peristalsis, hyoscine butylbromide (Bus-
copan, Sanofi) was administered in slow intravenous injec-
tion prior to SPIR-DWI and STIR-based DWI sequences as
well as the dynamic contrast sequences. A dosage of 10 mg
was used in patients under 50 kg, increased to 20 mg in pa-
tients of 50 kg or above, and the dose was diluted in 20 ml
of saline solution.
MRI image analysis. The measurements were performed
by one radiologist with 19 years of experience in gastroin-
testinal MRI imaging, and repeated by the same radiologist
after two months.
The measurement approach was standardised. Prior to
measurements, the whole parts of the inflamed terminal il-
eum were divided into approximately 3 cm long segments
(n = 32 in adult patients, n = 46 in children), and the below
process was performed when taking measurements in each
of the segments: 1) one measurement of bowel wall thick-
ness was performed in the location of the largest thickness;
2) presence/absence of ulcers was defined (1 – yes, 0 – no);
3) three measurements of ADC of the SPIR-based DWI
(Fig. 1a), and ADC of the STIR-based DWI (Fig. 2a) were
performed at the site of the maximum signal intensity (SI)
within the inflamed bowel wall. The ADC value along with
the chosen region of interest (ROI) was automatically
propagated on the corresponding ADC map (Figure 1b for
STIR- based DWI and 2.b for STIR-based DWI); 4) three
measurements of wall signal intensity (WSI) were taken
before (WSI-preGD) and after (WSI-postGd) administration
of gadolinium contrast medium in exactly the same loca-
tions of the highest SI in the bowel wall in both DWI se-
quences, 5) three measurements of the image noise — stan-
dard deviation (SD) were performed outside the patient’s
body before (SD-preGd) and after (SD-postGd) administra-
tion of the contrast medium (Rimola et al., 2009). The
ADC, WSI and SD measurements were performed using the
4–9 mm2 oval region of interest (ROI). The average values
of the three measurements of ADC, WSI and SD were used
for further calculations.
In each inflamed segment, the segmental MaRIA score was
calculated per equation:
1.5 × bowel thickness(mm) + 0.02 × RCE + 5 × oe-
dema + 10 × ulceration.
The presence of ulcers was rated as 1 and absence of ulcers
– as 0. RCE was calculated as: RCE = (WSI-postGd –
WSI-preGd)/(WSI-preGd)) × 100 × (SD-preGd/SD-
postGd), where the SD-preGd and SD-postGd corresponded
to the mean of the three SD values of the SI. This was
measured outside of the body before and after administra-
tion of gadolinium contrast medium, accordingly (Rimola et
al., 2009). Since oedema was a criterion of inclusion in the
study, it was present in all patients and was always equal
to 1.
The Clermont score, or DWI-MaRIA, for both SPIR- and
STIR-based DWI sequences, was calculated as:
DWI-MaRIA = 1.646 × bowel thickness - 1.321 × ADC +
5.613 × oedema + 8.306 × ulceration + 5.039 (Hordonneau
et al., 2014).
Fig. 1. Selecting the ROI in SPIR-based DWI images (b = 800 s/mm2) of
56 y.o. female (a). On the corresponding ADC map (b), the chosen ROI ap-
pears automatically.
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Similar to the calculation of the MaRIA score, presence of
ulcers was rated as 1, absence of ulcers as 0, and presence
of oedema was rated as 1.
The assessment of images and measurements of ADC val-
ues was performed using a dedicated post-processing server
Philips Intellispace Portal 5.0 (Philips Medical Systems,
Best, The Netherlands). WSI and image noise measure-
ments were performed using a Clear Canvas DICOM
Viewer, v. 13.2 (Synaptive Medical, Toronto, Canada,
2019).
Statistical analysis. Statistical analysis was performed us-
ing software Stata/IC (StataCorp LLC, Texas, USA). The
mean values and standard deviations were calculated for
SPIR- and STIR-based ADC, as well as RCE, MaRIA and
Clermont scores. The mean values of the first and second
measurement were compared, and statistical significance of
the differences was tested using a paired t-test; 95% confi-
dence intervals (CI) were calculated for differences. The
statistical significance of differences was determined using
one-way ANOVA with Bonferroni correction. A p value of
< 0.05 was considered as statistically significant. Differ-
ences in the presence/absence of ulcers was evaluated with
the Pearson’s 2 test.
RESULTS
No statistically significant difference was observed between
the two measurements performed by a single observer nei-
ther in the measurement of the bowel wall thickness (p =
0.42), nor in the assessment of ADC values of SPIR-based
DWI (p = 0.65) and ADC values of STIR-based DWI (p =
0.23). There was also no statistically significant difference
between the two measurements performed by a single ob-
server in assessment of WSI-preGd (p = 0.06) or WSI post-
Gd (p = 0.57). The highest absolute difference between two
measurements was observed for WSI-preGd measurements
(8%), and the lowest absolute difference for SPIR-based
ADC measurements (1%). The results of measurements,
along with absolute differences between the two measure-
ments, are presented in the Table 2.
For the assessment of presence of bowel ulcers between the
1st and the 2nd assessment, the Pearson 2 was 13.70 (p <
0.0005), indicating a systemic difference between the two
assessments for presence of ulcers. The results of the as-
sessment of presence/absence of ulcers are presented in Ta-
ble 3.
DISCUSSION
The therapeutic endpoint of CD treatment is to achieve and
maintain remission. Therefore, assessment of disease activ-
ity is crucial for guiding therapeutic decisions in treatment
of patients with CD. Apart from the resolution of symptoms
as the primary target (Shi et al., 2018), different grades of
activity such as clinical, biochemical and histopathological
activity, are considered. The concept of mucosal healing has
been under discussion for decades (Rogler et al., 2013) be-
ing associated with lower demand for steroids, reduced ad-
missions to hospital, and reduced need for surgical treat-
ment in case of complicated CD (D’Haens et al., 2008).
Fig. 2. Selecting the ROI in STIR-based DWI images of 56 y.o. female
(b = 800 s/mm2) (a). On the corresponding ADC map (b), the chosen ROI
appears automatically.







Wall thickness (mm) 6.4 6.6 0.2 (5%) 0.42
ADC of SPIR-based DWI (mm2/s) 1.219 (SD 0.320) 1.227 (SD 0.321) 0.008 (1%) 0.65
ADC of STIR-based (mm2/s) 1.180 (SD 0.505) 1.132 (SD 0.478) 0.048 (4%) 0.23
WSI-preGd 162.925 (SD 127.57) 150.305 (SD 99.68) 12.61 (8%) 0.06
WSI-post Gd 336.39 (SD 235.35) 316.11 (SD 212.90) 20.33 (6%) 0.57
ADC, apparent diffusion coefficients; WSI, wall signal intensity
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Mucosal healing has been accepted as an optimal therapeu-
tic target in clinical practice for many years; however, in pa-
tients with sustained mucosal healing, transmural inflamma-
tion may persist (Nardone et al., 2019). Transmural healing
is associated with better long-term outcomes than mucosal
healing, therefore transmural healing has recently been pro-
posed as a new target for CD treatment (Castiglione et al.,
2019). Since endoscopy does not provide transmural
evaluation even in the accessible regions of the gastrointes-
tinal tract, cross-sectional imaging studies (MR) have be-
come the mainstay of intestinal wall evaluation (Buisson et
al., 2019). Both mucosal and transmural healing can be as-
sessed with MRI (Panes et al., 2013; Maaser et al., 2019),
and according to the newest joint guidelines by European
Crohn's and Colitis Organisation (ECCO) and the European
Society of Gastrointestinal and Abdominal Radiologists
(ESGAR), MRI can be used as alternative for assessment of
disease activity (Maaser et al., 2019).
Calculations of MaRIA and Clermont indices include sev-
eral variables that are common to both indices, such as the
presence of ulcers and bowel wall oedema, and the thick-
ness of the gut wall. In the Clermont index, also called as
DWI-MaRIA, gadolinium contrast medium administration
is replaced by DWI (Rimola et al., 2009; Hordonneau et al.,
2014). Since 2009, this has been proven to be effective for
assessment of bowel inflammation. It has potential benefits
in the assessment of disease activity (Dohan et al., 2016)
and is used to replace contrast medium (Neubauer et al.,
2013). DWI reflects both anatomical and functional infor-
mation, providing data on diffusion restriction in the intesti-
nal wall that characterises an active inflammation (Dohan et
al., 2016), and is proven to be capable of detecting lesions
before their appearance in conventional images (Baliyan et
al., 2016). The DWI technique is however very sophisti-
cated, since it requires ideal magnetic field homogeneity,
very strong gradients and infinitively fast acquisition that is
not achievable with existing MRI machines. The quality of
DWI images is therefore lesser than that of conventional
MR images, due to low resolution, noise, distortions, and
limited morphological interpretability (Chilla et al., 2015);
therefore, DWI provides functional rather than anatomical
information. Opinions on reproducibility of ADC-DWI
measurements used in the Clermont score varies among
authors, and despite good to excellent repeatability reported
from certain authors (Yu et al., 2019), contrary concerns on
low reproducibility based on research data also exist (Wat-
son et al., 2018). Due to equivocal data on repeatability of
measurements the form the MaRIA and Clermont score, our
interest was to assess the repeatability of measurements
contributing to both of these indices — WSI-preGd and
WSI-postGD forming RCE in MaRIA, ADC-DWI used in
the Clermont score, as well as bowel thickness and estima-
tion of presence of bowel ulcers, which are common to both
MaRIA and Clermont scores.
There are numerous DWI techniques, all of which are based
on fat suppression, which is necessary for artefact reduction
(Takahara et al., 2004). These techniques can be classified
into fat, or spectral, selective and non-selective ones, based
on different behaviour among lipid protons and hydrogen
protons from water during MR imaging. In selective fat
suppression, protons of proper resonance frequency of fat
are suppressed, whereas in non-selective fat suppression the
difference in T1 between protons in water and fat tissue is
used to suppress the fat signal with inversion-recovery tech-
nique (Delfaut et al., 1999). In our institution, apart from
selective SPIR-based DWI, a non-selective STIR-based fat
suppression technique was evaluated in the study due to bet-
ter image quality (Ouyang et al., 2014), i.e. visually sharper
images and more clearly differentiated contours of struc-
tures (Fig. 3), and superiority of ADC measurements over
DWI with selective fat suppression in assessment of other
tissues, such as breast lesions (Stadlbauer et al., 2009). This
technique could theoretically improve the accuracy of the
assessment of disease activity in the intestinal wall. In our
study, intra-observer reproducibility of both SPIR- and
Table 3. Evaluation of 1st and 2nd measurements of the presence/absence of
ulcers
Evaluation Ulceration No. of
segments
% Pearson 2 p-value
First Absence 43 55.13
13.70 < 0.0005Presence 35 44.87
Second Absence 26 33.33
Presence 52 66.67
Fig. 3. DWI (a) and DWIBS (b) images of high diffusion gradient b value
= 800 mm2/s in a 56-year-old female patient with active Crohn’s disease.
Inflamed bowel walls present high signal intensity. The resolution of in-
flamed bowel and delineation of contours is better in the STIR-based DWI
image (black arrows) than in the DWI image (white arrows).
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STIR-based DWI techniques was good, since no statisti-
cally significant difference was found between mean values
in both ADC of SPIR-based DWI (p = 0.65), as well as
ADC of STIR-based DWI (p = 0.23), and difference be-
tween mean values of ADC was only 1% in SPIR-based
DWI and 4% in STIR-based DWI (Table 1). However, un-
like breast tissue, ADC measurements of STIR-based DWI
quantitative may not be of practical importance in assess-
ment of bowel walls, due to non-selectivity of fat suppres-
sion; not only signals from fat, but other media of short T1
time, such as proteinaceous, viscous and mucous sub-
stances, methaemoglobin products (Grande et al., 2014), as
well as chime and faeces (Kwee et al., 2008) are sup-
pressed. Since DWI has a strong partial volume effect
(Scherrer et al., 2011), the measured ADC values in STIR-
based images could be artificially lower in the presence of
these substances (Apine et al., 2019).
Several authors found poor repeatability of RCE measure-
ments (Sharman et al., 2009; Tielbeek et al., 2013). We
found no statistically significant difference in WSI-preGd
(p = 0.06), or in WSI post-Gd (p = 0.57) values used in cal-
culating of RCE. We believe that a strict definition of ROI
size and accurate site-by-site WSI-preGd and post-Gd
measurement in one and the same bowel segment, would re-
sult in good inter-observer agreement. It has however to be
noted that our results show high standard deviations in both
WSI-preGD (SD 127.57 for the 1st assessment and SD
99.68 for the 2nd assessment) and WSI-post-Gd measure-
ments (SD 235.35 for the 1st assessment and SD 212.9 for
the 2nd assessment) covering 66–78% of the WSI values.
Our observations suggest that, if WSI-preGd values were in
the tens, the WSI-post Gd values would also be in the tens;
if WSI-preGd values were in the hundreds, this would also
be replicated in the WSI-post Gd values. We explain this
observation through individual tissue characteristics of pa-
tients, magnetic field inhomogeneity and linearity of gradi-
ents yielding wide distribution of WSI values. Detailed
analysis of this finding, however, is beyond the scope of our
current research.
Tielbeek et al. (2013) reported moderate repeatability of
bowel thickness measurements and excellent repeatability
when the thickness measurements were performed by an ex-
perienced radiologist. In our study, no statistically signifi-
cant difference was found between the 1st and the 2nd meas-
urements. It should, however, be noted that wall thickness
differed within one and the same bowel segment, and the
maximum thickness was always chosen for the calculations.
However, identifying the same exact location of the maxi-
mum thickness often was not possible in DWI images due
to their low spatial resolution. Similarly, in the pre- and
post-contrast series, bowel thickness was always measured
in the axial images but pre- and post-T1 images were ac-
quired in the coronal plane.
In our study, there was a systematic difference in the assess-
ment of ulcers. The inconsistency of ulcer detection in our
study could be associated with lack of strict consensus re-
garding standardised MR definition of an ulcer. Developers
of the MaRIA index defined ulcers as deep depressions in
the mucosal surface (Rimola et al., 2009). However, MRI
reveals a wide range of ulcers. Even small aphthous ulcers
can be seen in MRI images (Ram et al., 2016), and there is
no clear definition of the size and appearance of ulcers that
should be included in calculation of disease activity indices
or excluded from it. Intra-observer agreement of the ulcer
rating could be improved with a 3T MR scanner, as this
provides better spatial and temporal resolution, and litera-
ture data indicates that the resolution of 3T MR in ulcer di-
agnosis is superior compared to that of the 1.5T device (Fi-
orino et al., 2013).
Due to lack of data, histopathological findings were not
used as the reference standard in our study. The patients
were enrolled in the study only by visual MRE signs of
Crohn’s disease, i.e. thickened, oedematous bowel wall and
significantly increased SI in the DWI images with diffusion
gradient value of b = 800 s/mm2, and low SI on the ADC
map. However, the aim of our study was not to investigate
the relationship of visual findings with histological findings,
but rather whether repeated measurements, based on certain
defined MRE criteria for the evaluation of Crohn's disease
activity, produced comparable results. Literature provides a
broad picture of the correlation not only between MRE and
endoscopic findings, but also between MRE and surgical
specimens of resected intestinal segments, with certain de-
fined criteria, along with conclusion that MRI is an infor-
mative and sufficiently accurate method to assess altered
bowel wall. Based on these observations, for several years
now when referring patients for MRE examinations, clini-
cians do not duplicate its results with invasive endoscopy,
which is cumbersome for patients. Consequently, in 2019,
for the first time, the ECCO-ESGAR guidelines (Maaser et
al., 2019) came up with a revolutionary statement that ra-
diological cross-sectional imaging methods, including MR,
can be used as an alternative to endoscopy to assess Crohn’s
disease activity. Therefore, although all patients in our
study had endoscopically confirmed Crohn's disease, the re-
sults of the MRE examination were not duplicated by the
endoscopic findings in any cases. Consequently, the correla-
tion of the MR activity indices with the histopathological
and endoscopic activity indices was not possible. It should
also be noted that the correlation of the MR findings with
the endoscopic image is still relative. The endoscopical and
histopathological findings, including endoscopically ob-
tained tissue specimens, reflect changes in the intestinal mu-
cosa, whereas the MR activity indices include not only mu-
cosal but also transmural components. Both literature data
and the experience from our hospital indicate situations
when intact intestinal mucosa is observed endoscopically in
active Crohn's disease. The correlation of histopathological-
radiological findings could be most accurately reflected in
the resection specimen after bowel surgery. Resection of the
altered intestinal segment was performed only in one of the
patients enrolled in our study.
There may be a methodological error in using correlation
between MaRIA and Clermont score, since these indices
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mostly contain the same components, except that RCE is
used in MaRIA and ADC value in Clermont score, leading
to overestimation of actual correlation. However, the goal
of this study was to assess the repeatability of all necessary
measurements without analysing the shortcomings of meth-
odology of assessment of their correlation. A wider discus-
sion on the application of the correlation coefficient, with
references to literature sources, will be discussed in another
publication currently awaiting approval.
In our opinion, the strengths of our study were: 1) the pro-
spective study design, 2) exact site-by-site comparison in
the same bowel segment, and 3) exact ROI size that was not
defined in studies on MaRIA and Clermont scores. The lim-
itations of our research were as follows: 1) the relatively
low number of participants in the study groups, 2) the study
group included both adults and paediatric patients causing
lack of homogeneity regarding the length of the disease or
treatment status. However, a mixed data poll of adult and
paediatric patients was chosen because the methodology of
all measurements (bowel wall thickness, WSI-preGd, WSI-
postGd, ADC of SPIR-based DWI, ADC of STIR-based
DWI and estimation of ulcers) was identical for both adults
and children. Therefore, the estimations of intra- observer
agreement were not influenced by the age of patients. Un-
like adults, estimation of disease activity in children does
not rely on endoscopy findings due to its invasiveness, but
rather on the Paediatric Crohn's Disease Activity Index
(PCDAI) (Rozendorn et al., 2018). In children, the utility of
MaRIA and Clermont score is still unclear, and accordingly,
the relationship of RCE and DWI-based ADC with actual
Crohn’s disease activity is unclear.
CONCLUSIONS
The reproducibility of ADC-DWI, WSI-preGd and WSI-
post Gd measurements used in calculation of MRE-based
indices for quantification of Crohn's disease inflammation is
high when standardised conditions, such as proper ROI size
and exact site-to site comparison are clearly defined and ob-
served. Effort still needs to be made in defining the size and
appearance of ulcers that should either be included in the
calculation of Crohn’s disease activity indexes, or excluded
from it.
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KRONA SLIMÎBAS AKTIVITÂTES IZVÇRTÇÐANÂ IZMANTOTO MAGNÇTISKÂS REZONANSES MÇRÎJUMU
ATKÂRTOJAMÎBA
Pçtîjuma mçríis bija izvçrtçt ileum distâlajâ cilpâ lokalizçtas Kroina slimîbas aktivitâtes noteikðanas parametru atkârtojamîbu. Pçtîjumâ tika
iekïauti 5 pieauguðie (23-57 g.v.) un 12 bçrni (11-17 g.v.) ar aktîvu terminâlo ileîtu. Iekaisuma skartâ zarnas siena tika sadalîta 3 cm garos
segmentos (n = 32 pieauguðiem, n=46 bçrniem), un veikti MaRIA indeksa un Klçrmontas indeksa aprçíinâðanai nepiecieðamie mçrîjumi:
acîmredzamâs difûzijas koeficienti (ADC) difûzijas uzsvçrto attçlu (DWI) sekvencçs ar selektîvu un neselektîvu tauku nospieðanu, zarnas
sieniòu signâla intensitâte (WSI - Wall Signal intensity) pirms (WSI-preGd) un pçc (WSI-post-Gd) i/v gadolînijas kontrastvielas ievades,
zarnu sieniòas biezums, kâ arî noteikta èûlu klâtbûtne. Mçrîjumus, veicot precîzu segmentu salîdzinâðanu noteiktâs lokalizâcijâs un
definçjot noteiktu izpçtes apgabala (ROI - Region of Interest) lielumu, standartizçja un pçc 2 mçneðiem atkârtoja viens un tas pats radiologs.
ADC, WSI-preGd un WSI-postGd, zarnu sieniòu biezuma, mçrîjumu atkârtojamîba viena novçrotâja robeþâs tika izvçrtçta ar pâru t-testu.
Èûlu klâtbûtnes vçrtçjuma atkârtojamîba tika izvçrtçta ar Pearson 2 testu. Starp 1. un 2. mçrîjumu netika konstatçta statistiski ticama ADC,
WSI-preGd, WSI-postGd un sienas biezuma mçrîjumu atðíirîba. Konstatçta statistiski nozîmîga atðíirîba èûlu klâtbûtnes izvçrtçðanâ.
Standartizçtos apstâkïos ADC, WSI-preGd un WSI-postGd atkârtojamîba ir augsta. Nepiecieðami tâlâki pçtîjumi, lai noteiktu kritçrijus èûlu
lieluma un izskata definçjumam.
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